Please assess the completion status of the following clinical trial:

Trial Title: Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who are at least 18 years of age.~* Subjects who are candidates for routine, uncomplicated cataract surgery.~* Subjects who, in the Investigator's opinion, have potential postoperative pinholed Snellen visual acuity (VA) of at least 20/200 in the study eye.~Exclusion Criteria:~* Subjects who have known hypersensitivity or contraindication to the study drug or components.~* Subjects with a severe/serious ocular condition, or any other unstable medical condition, that in the investigator's opinion may preclude study treatment or follow-up.~* Subjects with elevated intraocular pressure (\>/= 21mm Hg), uncontrolled glaucoma, or being treated for glaucoma in the study eye.~* Subjects who are monocular or have pinholed Snellen VA 20/200 or worse in the non-study eye.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Loteprednol Etabonate (Type: EXPERIMENTAL): Loteprednol etabonate
- Vehicle (Type: PLACEBO_COMPARATOR): Vehicle of loteprednol etabonate

Based on this trial design, predict the completion outcome and termination type (if applicable).